153 results on '"Lemoine Sandrine"'
Search Results
2. #2278 EUROCYS, a European cystinuria registry
3. #1096 Improving the diagnostic accuracy of absorptive hypercalciuria: a comparative analysis of calcium load tests at 2-hour and 4-hour intervals
4. #2245 ECYSCO, a European cystinosis cohort
5. #1964 Diagnosis performance of urine oxalate/creatinine ratio for hyperoxaluria screening
6. #2879 Residual kidney function is more than urinary output alone in PD patients: insights derived from tubular functional Na MRI of the kidney
7. #337 Renal 3D photoacoustic imaging and contrast-enhanced ultrasound to assess oxygenation and perfusion and to predict fibrosis after ischemia-reperfusion
8. Nedosiran Safety and Efficacy in PH1: Interim Analysis of PHYOX3
9. Dolutegravir-induced severe sideroblastic anemia
10. 23NaMRI Assessed Cyst Sodium Concentration in Polycystic Kidney Disease to Identify Cyst Metabolic Activity: A Proof of Concept Study
11. Lumasiran, Isolated Kidney Transplantation, and Continued Vigilance
12. An Open-label Phase 2 Study of Eneboparatide, a Novel PTH Receptor 1 Agonist, in Hypoparathyroidism
13. Circulating Oxalate Levels in Short Bowel Syndrome as a Severity Marker of CKD
14. X-linked hypophosphatemia: The value of feedback focus groups to assess patient and caregiver needs
15. Is shrunken pore syndrome also a reality in children?
16. Extending the cystatin C based EKFC-equation to children – validation results from Europe
17. Reassuring data on the cardiovascular risk in adults with X-linked hypophosphatemia receiving conventional therapy
18. SAT237 AZP-3601, A Novel PTH 1 Receptor Agonist, Induces Rapid Reduction And Normalization Of Urinary Calcium In Chronic Hypoparathyroid Patients
19. OR23-04 Treatment Of Chronic Hypoparathyroidism With Eneboparatide (AZP-3601), A Novel PTH 1 Receptor Agonist: Results From A Phase 2 Trial
20. Heat Shock Protein 70 Is Involved in the Efficiency of Preconditioning with Cyclosporine A in Renal Ischemia Reperfusion Injury by Modulating Mitochondrial Functions
21. Average creatinine-urea clearance: Revival of an old analytical technique?
22. Eneboparatide, a novel PTH 1 receptor agonist, induces rapid reduction and normalization of urinary calcium in chronic hypoparathyroid patients
23. Treatment of chronic hypoparathyroidism by Eneboparatide, a novel PTH receptor-1 agonist: Results from a phase 2a study
24. Impact of race-independent equations on estimating glomerular filtration rate for the assessment of kidney dysfunction in liver disease
25. Challenges and Opportunities in Titrating Disease-Modifying Therapies in Heart Failure with Reduced Ejection Fraction and Chronic Kidney Disease
26. Petits ARN interférents : applications potentielles pour les néphrologues Small interfering RNA: potential applications for nephrologists
27. Initial evaluation of extracorporeal immunomodulatory therapy for the treatment of critically ill COVID-19 infected patients
28. HIV-1-Associated Kidney Disease in an Elite Controller
29. X-Linked Hypophosphatemia, Not Only a Skeletal Disease But Also a Chronic Inflammatory State
30. Impact of race-independent equations on estimating glomerular filtration rate for the assessment of kidney dysfunction in liver disease
31. Mild Therapeutic Hypothermia Protects from Acute and Chronic Renal Ischemia-Reperfusion Injury in Mice by Mitigated Mitochondrial Dysfunction and Modulation of Local and Systemic Inflammation
32. Point of care creatinine derived eGFR measurement in capillary blood for identifying patients at risk
33. Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis
34. Calcium homeostasis and hyperparathyroidism: Nephrologic and endocrinologic points of view
35. Histological and genetic characterization and follow-up of 130 patients with chronic triple-negative thrombocytosis
36. Estimation of glomerular filtration rate for drug dosing in patients with very high or low body mass index
37. Reloxaliase in Enteric Hyperoxaluria — The Recent Brake
38. Fluconazole in hypercalciuric patients with increased 1,25(OH)2D levels: the prospective, randomized, placebo-controlled, double-blind FLUCOLITH trial
39. Prediction Tool to Estimate Potassium Diet in Chronic Kidney Disease Patients Developed Using a Machine Learning Tool: The UniverSel Study
40. Effects of pediatric chronic kidney disease and its etiology on tissue sodium concentration: a pilot study
41. Extracellular cold-inducible RNA-binding protein (eCIRP), a novel inflammatory biomarker to assess ischemia-reperfusion injuries, and protection conferred by mild therapeutic hypothermia
42. RENIN ANGIOTENSIN SYSTEM BLOCKADE AT BEDTIME VERSUS ON AWAKENING TO PREVENT ALDOSTERONE BREAKTHROUGH
43. Functional Sodium MRI Helps to Measure Corticomedullary Sodium Content in Normal and Diseased Human Kidneys
44. MO095: Normocalcaemic Hyperparathyroidia Diagnosed by Calcium Load
45. MO645: Does Sodium Magnetic Resonance Imaging Help for Initiation of Incremental Dialysis?
46. Kidney function monitoring in inflammatory bowel disease: The MONITORED consensus
47. Outcomes and predictors of skin sodium concentration in dialysis patients
48. Fluconazole in Hypercalciuric Patients with Increased 1,25(OH)2D Levels: The Prospective, Randomized, Placebo-Controlled, Double Blind FLUCOLITH Trial.
49. Estimating Glomerular Filtration Rate from Serum Myo-Inositol, Valine, Creatinine and Cystatin C
50. Tubular phosphate handling: references from child to adulthood in the era of standardized serum creatinine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.